Fibroblasts from patients with I-cell disease and pseudo-Hurler polydystrophy are deficient in uridine 5'-diphosphate-N-acetylglucosamine: glycoprotein N-acetylglucosaminylphosphotransferase activity.
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Newly synthesized acid hydrolases, destined for transport to lysosomes, acquire a phosphomannosyl targeting signal by the transfer of N-acetylglucosamine 1-phosphate from uridine 5'-diphosphate (UDP)-N-acetylglucosamine to a mannose residue of the acid hydrolase followed by removal of the outer, phosphodiester-linked N-acetylglucosamine to expose 6-phosphomannose. This study demonstrates that fibroblasts from patients with the lysosomal enzyme storage diseases, I-cell disease (mucolipidosis II) and pseudo-Hurler polydystrophy (mucolipidosis III), are severely deficient in UDP-N-acetylglucosamine:glycoprotein N-acetylglucosaminylphosphotransferase, the first enzyme of the sequence. The N-acetylglucosaminylphosphotransferase activity (assayed using endogenous acceptors) in cultures from six normal subjects ranged from 0.67 to 1.46 pmol N-acetylglucosamine-1-phosphate transferred/mg protein per h, whereas five pseudo-Hurler polydystrophy and five I-cell disease cultures transferred less than 0.02 pmol/mg protein per h. The activity in five other pseudo-Hurler cultures ranged from 0.02 to 0.27 pmol transferred/mg protein per h. The activity of alpha-N-acetylglucosaminyl phosphodiesterase, the enzyme responsible for phosphomonoester exposure, is normal or elevated in cultured fibroblasts from both I-cell disease and pseudo-Hurler polydystrophy patients. The deficiency of UDP-N-acetylglucosamine:glycoprotein N-acetylglucosaminylphosphotransferase explains the biochemical abnormalities previously observed in I-cell disease and pseudo-Hurler polydystrophy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Kaplan, A., Achord, D. T., & Sly, W. S. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.5.2026 · Cited by 574
A hypothesis for I-cell disease: Defective hydrolases that do not enter lysosomes
Hickman, S., & Neufeld, E. F. (1972) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(72)90310-5 · Cited by 444
Biosynthesis of lysosomal enzymes in fibroblasts. Phosphorylation of mannose residues
Hasilik, A., & Neufeld, E. F. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85586-2 · Cited by 400
Structural studies of phosphorylated high mannose-type oligosaccharides.
Varki, A., & Kornfeld, S. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70385-8 · Cited by 236
Self-citationReitman, M. L., & Kornfeld, S. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)69430-5 · Cited by 229
Self-citationTabas, I., & Kornfeld, S. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43616-2 · Cited by 223
Self-citationNatowicz, M. R., Chi, M. M., Lowry, O. H., & Sly, W. S. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4322 · Cited by 213
The substrate specificities of endo-β-N-acetylglucosaminidases CII and H
Tai, T., Yamashita, K., & Kobata, A. (1977) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(77)91273-6 · Cited by 195
Varki, A., & Kornfeld, S. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43507-7 · Cited by 174
Self-citation
Research works printed but not linked: 2
- J. B. Stanbury, J. B. Wyngaarden, and D. S. Fredrick- son, editors, McGraw-Hill Book Company, New York. 1299-1302.
- Reitman, M. L., and S. Komfeld. 1981. UDP-N-acetyl- glucosamine: glycoprotein N-acetylglucosamine-l-phos- photransferase-proposed enzyme for the phosphoryla- tion of the high mannose oligosaccharide units of lyso- somal enzymes. J. Biol. Chem. 256: in press.
Cited by
Items 201–300 of 323
González‐Noriega, A., Coutiño, R., Saavedra, V., & Rodríguez, R. B. (1989) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(89)90333-0 · Cited by 10
Mueller, O. T., Little, L. E., Miller, A. L., Lozzio, C. B., & Shows, T. B. (1985) · Clinica Chimica Acta · doi:10.1016/0009-8981(85)90242-6 · Cited by 12
Zeng, J., Hassan, A., & Morales, C. R. (2004) · Molecular Reproduction and Development · doi:10.1002/mrd.20097 · Cited by 9
“Earlier reports from several laboratories have demonstrated that this SAP is targeted to the lysosomes in a M6P-R independent manner (Rijnboutt et al., 1991).”
BackgroundInfluentialBarnes, J. W., Aarnio, M., Norris, J. W., Haskins, M. E., Flanagan‐Steet, H. R., & Steet, R. (2020) · Biomolecules · doi:10.3390/biom10050670 · Cited by 9
“The lysosomal disease mucolipidosis type II (ML-II) is caused by a defect in the biosynthesis of mannose 6-phosphate (Man-6-P) residues, the carbohydrate-based tag responsible for lysosomal targeting of acid hydrolases [1,2].”
BackgroundMucolipidosis in a Chinese family with compound heterozygous mutations at the GNPTAB gene
Zhan, T., Cui, X., Xuenong, X., Ren, A., Gan, G., Liu, Y., Zhang, J., Tang, Z., & Liu, M. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.04.025 · Cited by 9
I-cell disease and pseudo-Hurler polydystrophy
Durand, P., Pelizza, A., Borrone, C., & Gatti, R. (1982) · Springer eBooks · doi:10.1007/978-3-642-51582-8_8 · Cited by 11
Ben‐Yoseph, Y., Potier, M., Mitchell, D. A., Pack, B. A., Melançon, S. B., & Nadler, H. L. (1987) · Biochemical Journal · doi:10.1042/bj2480697 · Cited by 9
Neuroanatomical anomalies associated with rareAP4E1mutations in people who stutter
Chow, H. M., Li, H., Liu, S., Domingues, C. E. F., & Drayna, D. T. (2021) · Brain Communications · doi:10.1093/braincomms/fcab266 · Cited by 8
Renwick, N. M., Nasr, S. H., Chung, W. K., Garvin, J., Markowitz, G. S., Marboe, C. C., Thaker, H. M., & D’Agati, V. D. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00133-1 · Cited by 8
Biochemical phenotyping of a single sibship with both cystinosis and fabry disease
Gahl, W. A., Adamson, M. D., Kaiser‐Kupfer, I., Ludwig, I., O'Connell, H. J., Cohen, W. E., & Barranger, J. A. (1984) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01819297 · Cited by 8
Characterization of glucocerebrosidase in peripheral blood cells and cultured blastoid cells
Aerts, J. M. F. G., Heikoop, J. C., van Weely, S., Donker‐Koopman, W. E., Barranger, J. A., Tager, J. M., & Schram, A. W. (1988) · Experimental Cell Research · doi:10.1016/0014-4827(88)90472-7 · Cited by 8
Koga, M., Ishihara, T., Hoshii, Y., Uchino, F., Matsuo, K., & Yamashita, Y. (1994) · Pathology International · doi:10.1111/j.1440-1827.1994.tb02596.x · Cited by 8
Oohira, A., Matsui, F., Oki, T., & Nogami, H. (1987) · Journal of Cell Science · doi:10.1242/jcs.87.2.249 · Cited by 8
Chapter 16a Carbohydrate-deficient glycoprotein syndrome
Yamashita, K., & Ohno, K. (1996) · New comprehensive biochemistry · doi:10.1016/s0167-7306(08)60302-6 · Cited by 8
Braulke, T., Tippmer, S., Matzner, U., Gartung, C., & FIGURA, K. V. (1992) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(92)90012-c · Cited by 8
Madiyalakan, R., An, S., Jain, R. K., & Matta, K. L. (1985) · Carbohydrate Research · doi:10.1016/s0008-6215(00)90415-4 · Cited by 8
Heterogeneity in mucolipidosis II (l‐cell disease)
Okada, S., Kato, T., Oshima, T., Yutaka, T., & Yabuuchi, H. (1983) · Clinical Genetics · doi:10.1111/j.1399-0004.1983.tb01865.x · Cited by 8
A study of highly purified mucolipidosis III urinary N-acetyl-β-D-hexosaminidase B
Hirani, S., Little, L. E., & Miller, A. L. (1982) · Biochemical Journal · doi:10.1042/bj2040557 · Cited by 8
LYSOSOMAL STORAGE DISORDERS CAUSED BY INSTABILITY OF THE MISSING ENZYMES
FIGURA, K. V., Hasilík, A., & STECKEL, F. (1984) · Elsevier eBooks · doi:10.1016/b978-0-12-079280-1.50013-9 · Cited by 8
Tager, J. M., Aerts, J. M. F. G., JONSSON, L. M. V., Murray, G. J., van Weely, S., Strijland, A., Ginns, E. I., Reuser, A. J. J., Schram, A. W., & Barranger, J. A. (1986) · Springer eBooks · doi:10.1007/978-1-4684-5212-9_88 · Cited by 8
Lysosomal Degradation of Heparin and Heparan Sulfate
Meikle, P. J., Fuller, M., & Hopwood, J. J. (2005) · Elsevier eBooks · doi:10.1016/b978-008044859-6/50011-3 · Cited by 10
Danyukova, T., Ludwig, N. F., Velho, R. V., Harms, F. L., Güneş, N., Tidow, H., Schwartz, I. V. D., Tüysüz, B., & Pohl, S. (2019) · Human Mutation · doi:10.1002/humu.23928 · Cited by 7
An adult patient with mucolipidosis III alpha/beta presenting with parkinsonism
Hara, M., Inokuchi, T., Taniwaki, T., Otomo, T., Sakai, N., Matsuishi, T., & Yoshino, M. (2012) · Brain and Development · doi:10.1016/j.braindev.2012.07.009 · Cited by 7
Vladutiu, G. D. (1984) · Biochemical Journal · doi:10.1042/bj2180261 · Cited by 7
Biochemical diagnosis of genetic disease
GALJAARD, H. (1986) · Cellular and Molecular Life Sciences · doi:10.1007/bf01941280 · Cited by 7
PARTIAL DEFICIENCY OF GLYCOPROTEIN NEURAMINIDASE IN SOME PATIENTS WITH MORQUIO DISEASE TYPE A
Glössl, J., Kresse, H., Mendla, K. D., Cantz, M., & Rosenkranz, W. (1984) · Pediatric Research · doi:10.1203/00006450-198403000-00025 · Cited by 7
ROBBINS, A. R. (1988) · Elsevier eBooks · doi:10.1016/b978-0-12-203460-2.50015-9 · Cited by 8
Carbohydrate mediated recognition of lysosomal enzymes by cell surface receptors
FIGURA, K. V., Waheed, A., & Hasilík, A. (1983) · Journal of Biosciences · doi:10.1007/bf02702970 · Cited by 6
“Fibroblasts from patients with mucolipidosis III, a disease closely related to I-cell disease, show residual activities of the transferase of less than 10% of controls (Reitman et al., 1981; Waheed, Α., Hasilik, Α., Cantz, Μ. and von Figura K,unpublished).”
BackgroundGonzález‐Noriega, A., Michalak, C., & Sosa‐Melgarejo, J. A. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2005.01.002 · Cited by 6
Kornfeld, S. A. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-05-0417 · Cited by 6
“Proof that we had identified the correct pathway came from our studies showing that fibroblasts of patients with I-cell disease, an autosomal recessive lysosomal storage disorder characterized by hypersecretion of acid hydrolases due to the failure to synthesize the Man-6-P recognition marker, lack GlcNAc-P transferas…”
BackgroundSelf-citationBiochemical Characteristics of a Korean Patient with Mucolipidosis III (Pseudo-Hurler Polydystrophy)
Song, J., Lee, D. S., Cho, Y., Kim, J. Q., & Cho, T. (2003) · Journal of Korean Medical Science · doi:10.3346/jkms.2003.18.5.722 · Cited by 7
Poënaru, L., Castelnau, L., Tomé, F. M. S., Boué, J. G., & MAROTEAUX, P. (1988) · European Journal of Pediatrics · doi:10.1007/bf00442708 · Cited by 7
Yokoi, A., Niida, Y., Kuroda, M., Imi-Hashida, Y., Toma, T., & Yachie, A. (2018) · Pediatric Research · doi:10.1038/s41390-018-0234-2 · Cited by 6
Tran, M. L., Tüshaus, J., Kim, Y., Ramazanov, B. R., Devireddy, S., Lichtenthaler, S. F., Ferguson, S. M., & von Blume, J. (2022) · Traffic · doi:10.1111/tra.12873 · Cited by 6
Bush, J. M., Ebert, D. L., & Cardelli, J. A. (1990) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(90)90626-a · Cited by 6
Lemonnier, M., Derappe, C., Poënaru, L., Chester, M., Lundblad, A., Svensson, S., & Öckerman, P. (1982) · FEBS Letters · doi:10.1016/0014-5793(82)80062-8 · Cited by 6
I-cell disease (mucolipidosis II)
Kula, R. W., Shafiq, S. A., Sher, J. H., & Qazi, Q. H. (1984) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(84)90110-2 · Cited by 7
Calcification of intervertebral disks in I-cell disease
Mogle, P., Amitai, Y., Rotenberg, M., & Yatziv, S. (1986) · European Journal of Pediatrics · doi:10.1007/bf00446073 · Cited by 6
“Abbreviations: ICD = I-cell disease; IVDC = intervertebral disk calcification This disease is attributed to reduced activity of UDP-N-acetylglucosamine: glycoprotein-N-acetylglucosaminylphosphotransferase [2, 6].”
BackgroundEffects of flavonoids on enzyme secretion and endocytosis in normal and mucolipidosis II fibroblasts
Vladutiu, G. D., & Middleton, E. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90019-6 · Cited by 5
Defects in lysosomal enzyme trafficking
Hasilík, A., & Lemansky, P. (2004) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198508786.003.0006 · Cited by 5
Characterization of aspartylglucosaminidase activation and aspartylglucosaminuria mutations
Saarela, J. (2004) · Helda - University of Helsinki Institutional Repository · Cited by 5
MRI appearances of hip abnormalities in mucolipidosis, type III
Wihlborg, C., Babyn, P., & Clarke, J. T. R. (2000) · Pediatric Radiology · doi:10.1007/s002470050735 · Cited by 5
“Mucolipidosis III (ML-III) is caused by a deficiency of the enzyme N -acetylglucosaminyl-l-phosphotransferse (GlcNAc-PTase) [1].”
BackgroundPrenatal Diagnosis of I-cell Disease in the First and Second Trimesters
Parvathy, M., Mitchell, D. A., & Ben‐Yoseph, Y. (1989) · The American Journal of the Medical Sciences · doi:10.1097/00000441-198906000-00005 · Cited by 5
Lysosomes and Mononuclear Phagocytes
Stahl, P. D. (1983) · Springer eBooks · doi:10.1007/978-94-009-5975-0_6 · Cited by 5
GENETIC HETEROGENEITY IN LYSOSOMAL STORAGE DISORDERS STUDIED BY SOMATIC CELL HYBRIDIZATION
Reuser, A. J. J. (1984) · Elsevier eBooks · doi:10.1016/b978-0-12-079280-1.50024-3 · Cited by 6
Early diagnostic clues of mucolipidosis type II: Significance of radiological findings
Burgaç, E., Kaplan, İ., Köşeci, B., Kara, E., Kör, D., Bulut, F. D., Atmış, A., Pişkin, F. C., Bozdoğan, S. T., Demir, G. Ü., et al. (2024) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.63545 · Cited by 4
I-cell disease (Mucolipidosis II)
Kabra, M., Gulati, S., Kaur, M., Sharma, J., Singh, A. K., Chopra, V., Menon, P. S. N., & Kalra, V. (2000) · The Indian Journal of Pediatrics · doi:10.1007/bf02762185 · Cited by 4
González‐Noriega, A., Ortega-Cuéllar, D., & Michalak, C. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.12.019 · Cited by 4
Frézal, J., Merrer, M. F. L., & Chauvet, M.-L. (1997) · Pediatric Radiology · doi:10.1007/s002470050153 · Cited by 4
Yuasa, Y., Yoshinaga, M., Kitahara, T., Miyata, K., Shimozono, I., & Yoshida, H. (1990) · Pediatrics International · doi:10.1111/j.1442-200x.1990.tb00902.x · Cited by 4
Defective catabolism of low-density lipoprotein by fibroblasts from patients with I-cell disease
Williams, J., Weinstein, D. B., Miller, A. L., & Steinberg, D. H. (1982) · Biochemical Journal · doi:10.1042/bj2020183 · Cited by 4
Km defect in neuraminidase of dysmorphic type sialidosis with and without β-galactosidase deficiency
Ben‐Yoseph, Y., Momoi, T., Baylerian, M. S., & Nadler, H. L. (1982) · Clinica Chimica Acta · doi:10.1016/0009-8981(82)90167-x · Cited by 5
Urinary sialic acid screening in neurologic disorders
Carroll, J. E., Roesel, R. A., DuRant, R. H., Nelson, A. M., Hartlage, P. L., Hahn, D. A., & Hommes, F. A. (1986) · Pediatric Neurology · doi:10.1016/0887-8994(86)90059-7 · Cited by 4
Biosynthesis and Transport of Lysosomal Enzymes
Nygârd, O., & Westermann, P. (1983) · Humana Press eBooks · doi:10.1007/978-1-4612-5310-5_26 · Cited by 4
Processing and Sorting of Proteins Synthesized in the Endoplasmic Reticulum
Caplan, M. J., Rosenzweig, S. A., & Jamieson, J. D. (1986) · Springer eBooks · doi:10.1007/978-1-4613-2097-5_16 · Cited by 3
Annexin VI is a mannose-6-phosphate-independent endocytic receptor for bovine β-glucuronidase
Ramírez-Mata, A., Michalak, C., Mendoza‐Hernández, G., León‐Del‐Río, A., & González‐Noriega, A. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.05.025 · Cited by 3
Zhang, F., Bries, A. D., Lang, S. C., Wang, Q., Murhammer, D. W., Weiler, J. M., & Linhardt, R. J. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.08.006 · Cited by 3
Defects in transmembrane proteins
Ioannou, Y. A. (2004) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198508786.003.0009 · Cited by 3
Chapter 5. Prenatal Diagnosis of Inherited Metabolic Diseases: Principles, Pitfalls, and Prospects
Grabowski, G. A., & Desnick, R. J. (1982) · Methods in cell biology · doi:10.1016/s0091-679x(08)61365-5 · Cited by 3
Expression of lysosomal enzymes in human mutant fibroblast-chick erythrocyte heterokaryons
VANDERVEER, E. (1982) · Experimental Cell Research · doi:10.1016/0014-4827(82)90428-1 · Cited by 3
Neuraminidase assay in cultured human fibroblasts: in situ versus in vitro procedures
Beck, M., Scheuring, E., Voelter, H., Brandt, J., & HARZER, K. (1996) · Clinica Chimica Acta · doi:10.1016/0009-8981(96)06304-8 · Cited by 3
Thomas, G. H., Miller, C. S., TOOMEY, K. E., Reynolds, L. W., Reitman, M. L., Varki, A. P., Vannier, A., Rosebaum, K. N., Bias, W. Β., & Schofield, B. (1982) · PubMed · Cited by 3
Self-citationBinding receptors for ?-l-fucosidase in human B-lymphoid cell lines
DiCioccio, R. A., & Miller, A. L. (1992) · Glycoconjugate Journal · doi:10.1007/bf00731178 · Cited by 2
Jofré, G., Balmaceda, V., Sartor, T., Carvelli, L., Barrera, P., & Sosa, M. A. (2008) · Cells Tissues Organs · doi:10.1159/000159371 · Cited by 2
“…an inherited human disorder, newly synthesized lysosomal enzymes do not acquire mannose-6-phosphate residues because the activity of phosphotransferases is severely reduced or eliminated [Hasilik et al., 1981; Reitman et al., 1981] and acid hydrolases are quantitatively secreted by many cell types.”
BackgroundHearing impairment in two boys with I-cell disease
Ichiyama, T., Hayashi, T., & Matsuo, K. (1991) · Brain and Development · doi:10.1016/s0387-7604(12)80135-5 · Cited by 2
Sly, W. S., & Sundaram, V. (1985) · Elsevier eBooks · doi:10.1016/b978-0-407-02312-3.50010-7 · Cited by 2
Processing and Sorting of Proteins Synthesized in the Endoplasmic Reticulum
Caplan, M. J., Rosenzweig, S. A., & Jamieson, J. D. (1987) · Springer eBooks · doi:10.1007/978-1-4613-1943-6_16 · Cited by 2
Inborn Errors of Complex Carbohydrate Catabolism
Dawson, G., & Hancock, L. W. (1989) · Springer eBooks · doi:10.1007/978-1-4757-5955-6_15 · Cited by 2
Impaired Neutrophil Chemotaxis in Two Patients with Mucolipidosis II
Sakaguchi, T., Kikuchi, K., Ito, S., & Mikawa, H. (1988) · Acta Paediatrica · doi:10.1111/j.1651-2227.1988.tb10713.x · Cited by 2
The biochemical diagnosis of lysosomal storage diseases — A review of five years experience
Wallace, I. J. C., McCusker, C., & McCormick, D. (1990) · Irish Journal of Medical Science (1971 -) · doi:10.1007/bf02937266 · Cited by 2
Homozygosity for the variant ?-L-fucosidase trait and mucolipidosis III
Gatti, R., Lombardo, C., & Cardo, P. P. (1985) · Human Genetics · doi:10.1007/bf00389462 · Cited by 2
“Gaslini, Genova, Italy ation of the phosphomannosyl recognition marker of acid hydrolases for their targeting to the lysosomes (Reitman et al. 1981).”
BackgroundTargeting of lysosomal enzymes: N‐Acetylglucosamine‐1‐Phosphotransferase during muscle development
Den, H., Shanske, S., & DiMauro, S. (1986) · Muscle & Nerve · doi:10.1002/mus.880090311 · Cited by 2
EVIDENCE FOR A MANNOSE 6-PHOSPHATE-INDEPENDENT PATHWAY FOR LYSOSOMAL ENZYME TARGETING
Gabel, C. A., Goldberg, D. E., & Kornfeld, S. A. (1984) · Elsevier eBooks · doi:10.1016/b978-0-12-079280-1.50016-4 · Cited by 2
Self-citationDisruption of Man-6-P-Dependent Sorting to Lysosomes Confers IGF1R-Mediated Apoptosis Resistance
Aynaci, A., Toussaint, M., Gilis, F., Albert, M., Gaussin, J., Jadot, M., & Boonen, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083586 · Cited by 1
“Mucolipidosis III α / β and III γ are milder forms of the disease due to the residual GlcNAc-1-phosphotransferase activity [10,11].”
Lysosomal Enzyme GlcNAc-1- Phosphotransferase
Nishikawa, A. (2002) · Springer eBooks · doi:10.1007/978-4-431-67877-9_88 · Cited by 1
Lysosomal Biogenesis and Disease
Brooks, D. A., & Parkinson-Lawrence, E. J. (2007) · Springer eBooks · doi:10.1007/978-0-387-70909-3_2 · Cited by 1
Mucolipidosis III/psuedo-Hurler polydystrophy/N-acetyl-glucosaminyl-l-phosphotransferase deficiency
Nyhan, W., Barshop, B. A., & Ozand, P. (2005) · CRC Press eBooks · doi:10.1201/b13565-100 · Cited by 1
Chen, H. (2016) · Springer eBooks · doi:10.1007/978-1-4614-6430-3_166-2 · Cited by 1
Pyne, N. K., Bagel, J. H., Shyng, C., Odonnell, P., Miyadera, K., Srnak, J., Swain, G. P., Pesayco, J. P., Shelton, G. D., Assenmacher, C., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.04.030 · Cited by 1
Prenatal Diagnosis of Disorders of Carbohydrate Metabolism
Hug, G. (1986) · Springer eBooks · doi:10.1007/978-1-4684-5155-9_10 · Cited by 1
Enzymatic findings in a case of type II mucolipidosis
Maire, I., & Mathieu, M. (1982) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01799817 · Cited by 1
“I-cell disease (McKusick 25250) is a lysosomal storage disease resulting from the deficiency of a microsomal enzyme, the UDP-N-acetylglucosamine: glycoprotein N-acetylglucosamine phosphotransferase as has been recently demonstrated in fibroblasts (Reitman et al., 1981; Hasilik et al., 1981).”
BackgroundGlucose phosphotransferase and intracelular trafficking
Marchase, R. B., & Hiller, A. M. (1986) · Molecular and Cellular Biochemistry · doi:10.1007/bf00230638 · Cited by 1
How proteins are altered in genetic disease: an overview.
McInnes, R. R. (1991) · PubMed · Cited by 1
Brockhausen, I., & Kuhns, W. J. (1997) · Medical intelligence unit · doi:10.1007/978-3-662-21960-7_6 · Cited by 1
Études sur les sialidoses et les mucolipidoses
Beauregard, G., Melançon, S. B., Dallaire, L., & Potier, M. (1982) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(82)90489-7 · Cited by 1
Carbohydrate Deficiency Diseases
Brockhausen, I., & Kuhns, W. J. (1997) · Medical intelligence unit · doi:10.1007/978-3-662-21960-7_16 · Cited by 1
Madden, E. A., & Storrie, B. (1989) · Biochemical Journal · doi:10.1042/bj2580843 · Cited by 1
Mahuran, D. J., & Gravel, R. A. (1988) · Springer eBooks · doi:10.1007/978-1-4613-1029-7_26
Stoffwechselerkrankungen der Leber
Preisegger, K., & Denk, H. (2000) · Spezielle pathologische Anatomie · doi:10.1007/978-3-642-57036-0_5
Kollmann, K. (2008) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-273
Jirtle, R. L. (2002) · Wiley eBooks · doi:10.1002/047120918x.emb0880
Human biochemical genetics of enzyme proteins in the new age of molecular genetics
Swallow, D. M., & Hopkinson, D. A. (1986) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01800855
Immunoelectron Microscopical Localization of Lysosomal Hydrolases in Normal and I-Cell Fibroblasts
Willemsen, R., Hoogeveen, A. T., Reuser, A. J. J., & van Dongen, J. M. (1987) · Springer eBooks · doi:10.1007/978-1-4684-1283-3_13 · Cited by 1
Varki, A. P., Reitman, M. L., Tabas, I. A., & Kornfeld, S. A. (1983) · Journal of Biosciences · doi:10.1007/bf02702980
“Thus, the deficiency of the first enzyme in the pathway for the generation of the phosphomannosyl recognition marker can explain the biochemical abnormalities previously described in these diseases (Reitman et al., 1981).”
BackgroundSelf-citationMolecular interactions underlying neuronal ceroid lipofuscinoses CLN1 and CLN5
Lyly, A. (2008) · Helda - University of Helsinki Institutional Repository · Cited by 1
Dynamic microscopy: Reconstructing a novel lysosomal trafficking pathway
Yuan, L., Carvelli, F. L., & Morales, C. R. (2012) · CONICET Digital (CONICET)
Etude clinique epidemiologique et genetique de la mucolipidose de type II dans le nord-est du Quebec
Bordeleau, C. (1993) · Constellation (Université du Québec à Chicoutimi) · doi:10.1522/1483979
Progressive pathogenesis of juvenile neuronal ceroid lipofuscinosis.
Pontikis, C. C. (2005) · OpenGrey (Institut de l'Information Scientifique et Technique)
Roff, C. F., & Wozniak, R. W. (1982) · Elsevier eBooks · doi:10.1016/b978-0-12-333320-9.50048-9
The Oligosaccharidoses : Current State of Knowledge on Some of the Entities
Leroy, J. G. (1984) · Springer eBooks · doi:10.1007/978-94-009-5596-7_4
Metadata
- Authors
- Reitman, M. L., Varki, A., & Kornfeld, S.
- Affiliations
- Washington University in St. Louis (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1981-05-01
- Volume
- 67
- Issue
- 5
- Pages
- 1574-1579
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC370727
- OpenAlex
- W2118487772
- Cited by
- 321
- References
- 16
- Citations by year
- 2025: 2 · 2024: 4 · 2023: 1 · 2022: 3 · 2021: 3 · 2020: 5 · 2019: 4 · 2018: 5 · 2017: 3 · 2016: 4 · 2015: 1 · 2014: 1 · 2013: 2 · 2012: 7
- FWCI
- 35.25
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (CA08759)
- National Heart, Lung, and Blood Institute (T32HL007088)
- National Cancer Institute (R01CA008759)
- National Institute of General Medical Sciences (GM07200, T32GM007200)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Keywords
- I-cell disease, mucolipidosis II, mucolipidosis III, UDP-N-acetylglucosamine, lysosomal enzyme targeting, fibroblasts, lysosomal storage disease
- MeSH terms
- beta-Galactosidase, Cells, Cultured, Fibroblasts, Humans, Mucopolysaccharidosis I, Mucolipidoses, Phosphoric Diester Hydrolases, Phosphotransferases, Mucopolysaccharidosis II, Transferases (Other Substituted Phosphate Groups)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.